INSP - Inspire Medical Systems, Inc.
| Previous Close | 48.150 |
| Open | 48.220 |
| Bid | 48.130 x 800 |
| Ask | 48.620 x 900 |
| Day's Range | 48.090 - 49.800 |
| 52 Week Range | 22.500 - 50.000 |
| Volume | 55,640 |
| Avg. Volume | 221,020 |
| Market Cap | 1.031B |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.00 |
- GlobeNewswire•8 days ago
Inspire Medical Systems, Inc. Announces Second Quarter 2018 Financial Results
MINNEAPOLIS, Aug. 07, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- GlobeNewswire•29 days ago
Inspire Medical Systems, Inc. to Report Second Quarter 2018 Financial Results August 7, 2018
MINNEAPOLIS, July 17, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- American City Business Journals•last month
Inspire Medical CEO on going public, ramping up growth and ringing the stock-exchange bell
What former Medtronic exec Tim Herbert says about the $108 million IPO effort at Inspire Medical Systems Inc., which makes a device to treat sleep apnea.
- Benzinga•last month
Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 9) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Arrowhead Pharmaceuticals ...
- GlobeNewswire•last month
Inspire Medical Systems, Inc. Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
“We are very pleased to receive this positive coverage decision from Aetna. We believe this coverage decision is a major milestone and has the potential to facilitate patient and physician access to and interest in Inspire therapy,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. “There is a strong body of clinical data supporting Inspire therapy, including the 5-year STAR data, the ADHERE 300-patient registry data and other supportive publications. Under its policy, Aetna considers Inspire’s U.S. Food and Drug Administration (FDA) approved hypoglossal nerve neurostimulation device to be medically necessary for the treatment of moderate to severe OSA when a number of criteria are met. These include a previous attempt at continuous positive airway pressure (CPAP) treatment and patient selection consistent with FDA approval guidelines.
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy for Treatment of Moderate to Severe Obstructive Sleep Apnea in Japan
Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that Japan’s Ministry of Health, Labour and Welfare has approved its Inspire therapy to treat moderate to severe OSA. Inspire will be discussing the clinical outcomes and patient experiences with Japanese physicians at the Japanese Society of Sleep Research and the Asian Sleep Research Society (ASRS) meetings, which will be jointly held in Sapporo, Japan, on July 11–13, 2018.
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results
MINNEAPOLIS, June 07, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- ACCESSWIRE•2 months ago
Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks
WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.
- GlobeNewswire•3 months ago
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
MINNEAPOLIS, May 30, 2018-- Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with ...
- Benzinga•3 months ago
Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation
Not a month into Inspire Medical Systems Inc (NYSE: INSP)’s life as a publicly traded company, the Street is coming to consensus. “We believe Inspire Medical Systems is well positioned to disrupt the obstructive sleep apnea market over the next several years,” Block said in a note.
- InvestorPlace•3 months ago
3 New Healthcare Stocks to Buy Right Now
As we continue to age and populations grow, demand for new and innovative healthcare solutions is only growing as well. Already preliminary data shows that MOR208 could be a better therapy than the so-called cell therapies when used in combination to cure cancer.
- Benzinga•3 months ago
Inspire Medical Systems Goes Public
The medical technology company Inspire Medical Systems, Inc. (NYSE: INSP ) went public Thursday on the New York Stock Exchange. What Happened The company issued 6.75 million shares priced at $16 each. ...
